Optimising home oxygen delivery in infants has important logistical and safety implications. This can be aided by having a suitable reference range of normal values for arterial oxygen saturation using pulse oximetry (SpO 2 ).
INTRODUCTION
Pulse oximetry (SpO 2 ) has become the mainstay of assessment of oxygenation in preterm infants who have prolonged oxygen dependency. In the absence of randomized-controlled trials comparing the safety and efficacy of different SpO 2 levels, a pragmatic approach is to aim for normal SpO 2 levels.
Using a convenient system that can analyse the infant's oxygenation profile and compare it to a reference range for SpO 2 , we have previously reported such a reference range in a group of 33 infants born between 30 and 34 weeks gestation in the immediate postnatal period. 1 It is possible that this reference range could change, as the infant gets older. However, there are no longitudinal studies of SpO 2 in infants and children from birth to investigate this possibility.
The aims of this study were to describe oxygenation profiles in healthy preterm and term infants in relation to gestational and postnatal age and therefore to extend reference values to guide home oxygen therapy.
METHODS
Infants were recruited to the study between July 1998 and July 1999 at Liverpool Women's Hospital, UK, after local regional ethics committee approval had been granted. Infants who had received no mechanical ventilation or supplemental oxygen therapy were recruited after parental consent had been obtained. Infants with known congenital anomalies or cardio-respiratory disorders were excluded. Gestational age was determined from maternal dates and/or early antenatal ultrasound examination. All infants were studied for a continuous period of 4 hours following a feed, while asleep, or during a period of quiet wakefulness. Infants studied were grouped into the following gestational age bands: term infants Z37 weeks; preterm infants: <37 weeks.
Initial monitoring took place in term infants at least 48 hours postdelivery and after 1 week for the preterm infants. Subsequent monitoring took place in the infant's home at approximately 3, 6, 9 and 12 months postdelivery.
The monitoring of SpO 2 took place using a standard Ohmeda Biox 3700e pulse oximeter using an averaging interval of 3 seconds. A data-logging device and dedicated software, developed at the Department of Clinical Engineering, University of Liverpool, was used to record the data. Initial measurements took place on the neonatal unit or postnatal wards before discharge. Parents agreed to be contacted following discharge at the appropriate time intervals. At a convenient time, a dedicated research nurse (HP) visited the family, and instructed the parents in operating and recording oxygen saturations. Parents recorded four hours of data while the infant slept, generally at night time. Measurements on infants who were thought, in the opinion of the nurse, to have an acute respiratory illness were postponed until the child had clinically improved.
Analyses of raw data were performed blind to the infant's gestational or postnatal age. Using the group mean and lower 5th percentile, a cumulative frequency curve was constructed for each of the five recorded time intervals over the first year postdelivery. Descriptive statistics and graphs were generated using Microsoft Excel statistical software.
RESULTS
A total of 87 infants were recruited to the study and had baseline measurements performed. Median (range) gestational age for the term infants (n ¼ 34) was 40 weeks (37 to 41) and for the preterm infants (n ¼ 53) was 33 weeks (29 to 36). In all, 19 term infants and 23 preterm infants were male. Median (interquartile, IQR) age for the initial recording of term and preterm infants was 2 days (2 to 3) and 8 days (8-10), respectively. Median (IQR) age for each of the subsequent recordings for all infants postdelivery was: 14 weeks (13-16); 27 weeks (26 to 28); 40 weeks (39 to 42); and 52 weeks (51 to 53).
During the course of the study, 11 (13%) parents asked for their infant to be withdrawn from further follow-up. In addition, 46 (53%) of families, at some point over the next 12 months failed to respond to an initial attempt to contact them and a subsequent reminder. These families were deemed to have withdrawn themselves from the study from that time point onwards. The numbers of infants and median (range) gestational age of infants on whom follow-up data were obtained at 6 and 12 months for the term and preterm groups, respectively, was as follows. At 6 months, term group (n ¼ 15): 39 weeks (37 to 41); preterm group (n ¼ 32): 33 weeks (30 to 36). At 12 months, term group (n ¼ 11): 39 weeks (37 to 41); preterm group (n ¼ 19): 33 weeks (31 to 35). Figures 1 to 3 show the cumulative frequency for SpO 2 for term and preterm infants (along with the existing reference range) postdelivery, and at 6 and 12 months, respectively (curves for 3 and 9 months not shown). The mean and lower 5th centile are shown for each group, and similar data are shown of the reference data. 1 
CONCLUSIONS
In this study, we have prospectively followed a healthy term and preterm population of infants over a 12-month period and observed their SpO 2 . We have extended our reference range for increasing postnatal age using a data-logging device and dedicated software that is relatively simple and practical for routine use at home and in the nursery. infants only on a single occasion over the first 9 months postdelivery 4 or during childhood; 5,6 measured SpO 2 levels only during apnoeas or bradycardias; 7 or only performed repeat measures over the first four postnatal weeks. 8 Mean cumulative SpO 2 frequency for term and preterm infants were very similar over the initial 6-month follow-up, and corresponded to our existing reference range. 1 They diverged somewhat at 9 months and a year, where study numbers are reduced. Of note, the 5th centiles are markedly variable between groups, and compared to the existing reference range, particularly after the initial 3-month follow-up. The reasons for variation between curves may include: a fall in sample numbers over time; increasing movement artefact not detected with increasing postnatal age; difference in clinical characteristics between groups and with the original cohort; or some real differences between groups over time. Other factors that may contribute to variation in profiles include: idiopathic pulmonary hypertension; on-going alveolar development in preterm infants producing aberration in an otherwise healthy population; circadian rhythm; and sleep stage. In this pragmatic study, we think it appropriate to use these postnatal reference ranges for preterm infants in optimising home oxygen parameters rather than simply a postdelivery cohort, as it will allow for the possibility of differences due to artefact or otherwise.
The cumulative frequency curve of oxygen saturations represents the range of SpO 2 profiles in normal term and preterm infants. Such curves are helpful in guiding supplemental oxygen treatment as they provide a more visual, user-friendly display of the normal range than a single figure a mean (SD) SpO 2 does. 1 For example, by monitoring oxygen saturations over time in room air of an infant in whom it is thought that supplemental oxygen may be required, an individual SpO 2 profile can be constructed. This can be superimposed on the term or preterm reference curve for the appropriate postnatal age, and any deviation from the normal SpO 2 profile be assessed. Equally, a child on home oxygen could be monitored for ongoing requirement by comparing their SpO 2 profile in room air to the appropriate reference curve. A shift to the left (with a greater proportion of time spent at SpO 2 levels below the normal values) would indicate an ongoing oxygen requirement. Repeating the process in oxygen could confirm that the infants are receiving sufficient oxygen to ensure their oxygen saturation profile is within the normal range for healthy, gestational, age-matched infants.
This study has underlined the difficulty of following up a cohort longitudinally, with 22/34 (65%) of term infants and 25/53 (47%) of preterm infants dropping out over a 12-month period. It was thought withdrawal from the study was lower in the preterm group because the infant had initially been in hospital longer and had been more familiar with oxygen saturation monitoring as an inpatient, while the term infants were discharged much sooner, and had had less contact with staff.
Monitoring infants while undisturbed reflected our clinical practice of over-night saturation monitoring in children on home oxygen. Recording SpO 2 levels during activities such as feeding and handling may have increased inaccuracies related to movement artefact. It is acknowledged that with the advent of newer technology, motion tolerant low perfusion capable oximeters might have been able to produce more reproducible results. Restricting the duration of recording to 4 hours permitted a reasonable period of study, while maintaining the practicality of the methodology, and reducing the potential for added movement artefact. 9 The effects of prodromal illness on measurements were not excluded, as only those infants with actual symptoms had their date of monitoring postponed. Having defined our criteria for detecting major movement artefact, we cannot be certain of having excluded minor artefacts resulting in transient desaturation. The most likely effect of not detecting these events would have been to lower marginally the overall mean SpO 2 .
In summary, we have constructed normal reference ranges for cumulative SpO 2 for healthy term and preterm infants over a 12-month period. These data could be used to test the benefits in the home or hospital of having a reference range of normal values for cumulative SpO 2 .
